|
|
histone modification
|
GO:0016570 |
159 |
0.997
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.994
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.993
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.990
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.980
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.973
|
Mouse |
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.967
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.958
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.957
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.950
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.901
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.898
|
|
|
|
dna methylation involved in gamete generation
|
GO:0043046 |
15 |
0.890
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.848
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.843
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.839
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.826
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.821
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.814
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.811
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.779
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.778
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.770
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.762
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.761
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.751
|
Worm |
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.740
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
28 |
0.737
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.723
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.698
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.679
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.678
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.646
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.639
|
|
|
|
hypermethylation of cpg island
|
GO:0044027 |
3 |
0.632
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.605
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
47 |
0.582
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.580
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.563
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.515
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.510
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.498
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.494
|
Mouse |
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.485
|
|
|
|
regulation of histone h3 k9 methylation
|
GO:0051570 |
8 |
0.469
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.461
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.457
|
Mouse |
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.435
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.418
|
Worm |
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.414
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.402
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.395
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.394
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.392
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.389
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.386
|
|
|
|
olfactory learning
|
GO:0008355 |
2 |
0.383
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.382
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.358
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.357
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.351
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.338
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.329
|
|
|
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.319
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.318
|
Mouse |
|
|
gland development
|
GO:0048732 |
330 |
0.314
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.310
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.308
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.293
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.289
|
|
|
|
regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter
|
GO:0072364 |
7 |
0.288
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.288
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.282
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.280
|
|
|
|
chromatin silencing
|
GO:0006342 |
15 |
0.266
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.262
|
Mouse |
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.253
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.249
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.246
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.242
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.240
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.237
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.236
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.236
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.235
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.233
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.233
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.229
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.226
|
|
|
|
histone h4 k12 acetylation
|
GO:0043983 |
2 |
0.224
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.224
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.222
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.222
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.220
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.220
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.215
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0036003 |
3 |
0.215
|
|
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.214
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.210
|
|
|
|
dna modification
|
GO:0006304 |
50 |
0.207
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.206
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.204
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.199
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.193
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.188
|
Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.184
|
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.183
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.180
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.171
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.171
|
|
|
|
peptidyl lysine methylation
|
GO:0018022 |
29 |
0.168
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.167
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.167
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.156
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.154
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.153
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.153
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.153
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.152
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.151
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.150
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.149
|
Worm |
|
|
placenta development
|
GO:0001890 |
140 |
0.147
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.147
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.146
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.146
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.146
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.146
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.144
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.144
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.142
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.142
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.142
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.140
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.140
|
|
|
|
positive regulation of histone h3 k9 methylation
|
GO:0051574 |
4 |
0.138
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.137
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.135
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.133
|
Mouse |
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.130
|
|
|
|
locomotor rhythm
|
GO:0045475 |
8 |
0.128
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.128
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.126
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.126
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.123
|
|
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.123
|
|
|
|
external genitalia morphogenesis
|
GO:0035261 |
1 |
0.121
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.120
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.119
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.118
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.118
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.118
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.118
|
|
|
|
regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter
|
GO:0035947 |
7 |
0.116
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.115
|
|
|
|
regulation of dna templated transcription in response to stress
|
GO:0043620 |
9 |
0.115
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.114
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.114
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.113
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.113
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.112
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.112
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.112
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.111
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.110
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.110
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.110
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.109
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.109
|
|
|
|
neuroblast fate commitment
|
GO:0014017 |
1 |
0.109
|
|
|
|
stem cell fate commitment
|
GO:0048865 |
5 |
0.109
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.108
|
|
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.107
|
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.107
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.106
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.105
|
|
|
|
negative regulation of gene expression epigenetic
|
GO:0045814 |
15 |
0.105
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.104
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.102
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.102
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.100
|
|
|
|
serine phosphorylation of stat protein
|
GO:0042501 |
3 |
0.098
|
|
|
|
positive regulation of histone methylation
|
GO:0031062 |
16 |
0.097
|
|
|
|
male meiosis i
|
GO:0007141 |
16 |
0.096
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.095
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.094
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.093
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.093
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.093
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.092
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.092
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.092
|
Mouse |
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.092
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.092
|
|
|
|
positive regulation of gene silencing by mirna
|
GO:2000637 |
1 |
0.091
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.091
|
|
|
|
somatic diversification of t cell receptor genes
|
GO:0002568 |
5 |
0.091
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.090
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
17 |
0.090
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.089
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.088
|
Worm |
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.086
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.086
|
|
|
|
face development
|
GO:0060324 |
38 |
0.086
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.085
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.085
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.085
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.084
|
|
|
|
regulation of chromatin silencing
|
GO:0031935 |
2 |
0.084
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.083
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.083
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.083
|
|
|
|
regulation of dna templated transcription elongation
|
GO:0032784 |
10 |
0.082
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.082
|
|
|
|
gene silencing by rna
|
GO:0031047 |
19 |
0.082
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.080
|
|
|
|
n terminal protein amino acid modification
|
GO:0031365 |
6 |
0.079
|
Human |
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.079
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.079
|
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.079
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.078
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.078
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.077
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.077
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.076
|
Worm |
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.076
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.075
|
|
|
|
response to nitric oxide
|
GO:0071731 |
4 |
0.074
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.074
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.074
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.073
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.073
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.073
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.073
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.073
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.072
|
|
|
|
positive regulation of antimicrobial peptide biosynthetic process
|
GO:0002807 |
1 |
0.072
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.072
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.071
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.070
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.069
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.069
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.068
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.068
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
31 |
0.068
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.068
|
|
|
|
positive regulation of neuron death
|
GO:1901216 |
28 |
0.068
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.068
|
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.068
|
|
|
|
negative regulation of chromatin silencing
|
GO:0031936 |
1 |
0.067
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.067
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.067
|
|
|
|
regulation of cell cycle checkpoint
|
GO:1901976 |
9 |
0.066
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.065
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.065
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.065
|
|
|
|
mitotic sister chromatid cohesion
|
GO:0007064 |
1 |
0.065
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.064
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.064
|
|
|
|
gall bladder development
|
GO:0061010 |
2 |
0.063
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.063
|
Mouse |
|
|
microtubule based process
|
GO:0007017 |
236 |
0.063
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.063
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.063
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.062
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.062
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.062
|
|
|
|
regulation of dna damage checkpoint
|
GO:2000001 |
3 |
0.062
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.060
|
|
|
|
histone h3 k9 methylation
|
GO:0051567 |
17 |
0.060
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.059
|
Mouse |
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.059
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.059
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.059
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.059
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.059
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
69 |
0.058
|
|
|
|
chromatin silencing at rdna
|
GO:0000183 |
3 |
0.058
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.058
|
|
|
|
regulation of transcription involved in primary germ layer cell fate commitment
|
GO:0060796 |
2 |
0.057
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.057
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.057
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.057
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.057
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.057
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.057
|
|
|
|
nucleosome positioning
|
GO:0016584 |
4 |
0.057
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.056
|
|
|
|
regulation of transcription involved in cell fate commitment
|
GO:0060850 |
15 |
0.056
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
36 |
0.055
|
|
|
|
memory
|
GO:0007613 |
58 |
0.055
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.055
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.054
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.054
|
Worm |
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.054
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.054
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.054
|
|
|
|
type i pneumocyte differentiation
|
GO:0060509 |
7 |
0.052
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.052
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.052
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.052
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.052
|
|
|
|
negative regulation of nfat protein import into nucleus
|
GO:0051534 |
3 |
0.052
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.052
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.051
|
|
|
|
dna templated transcription elongation
|
GO:0006354 |
13 |
0.051
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.051
|
|
|
|
bmp signaling pathway involved in mesodermal cell fate specification
|
GO:0060803 |
1 |
0.051
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.051
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.050
|
|
|
|
mammary gland epithelial cell proliferation
|
GO:0033598 |
24 |
0.050
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.050
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.050
|
Worm |
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.050
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.050
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.049
|
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.049
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.049
|
|
|
|
dna hypermethylation
|
GO:0044026 |
3 |
0.049
|
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.049
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.049
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.048
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.048
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.048
|
Mouse |
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.048
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.047
|
|
|
|
genitalia development
|
GO:0048806 |
37 |
0.047
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.047
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.047
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
45 |
0.046
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.046
|
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.046
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.046
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.045
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.045
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.045
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.045
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.044
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.044
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.044
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.044
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.044
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.044
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.044
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.044
|
|
|
|
regulation of gene expression by genetic imprinting
|
GO:0006349 |
15 |
0.044
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.044
|
|
|
|
negative regulation of histone methylation
|
GO:0031061 |
10 |
0.044
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.043
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.042
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.042
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.042
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.042
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.042
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.042
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.042
|
|
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.042
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.042
|
|
|
|
regulation of dna binding
|
GO:0051101 |
39 |
0.041
|
|
|
|
rhombomere morphogenesis
|
GO:0021593 |
2 |
0.041
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.041
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.041
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.041
|
|
|
|
rig i signaling pathway
|
GO:0039529 |
4 |
0.041
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.041
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.041
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.040
|
|
|
|
endoderm formation
|
GO:0001706 |
20 |
0.040
|
|
|
|
chromatin remodeling
|
GO:0006338 |
32 |
0.040
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.040
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.040
|
Mouse |
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.040
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.040
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0043618 |
8 |
0.040
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.040
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.040
|
|
|
|
positive regulation of antibacterial peptide biosynthetic process
|
GO:0006963 |
1 |
0.040
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.040
|
|
|
|
regulation of stem cell maintenance
|
GO:2000036 |
17 |
0.040
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.039
|
|
|
|
antibacterial peptide production
|
GO:0002778 |
2 |
0.039
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.039
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.039
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.039
|
|
|
|
circadian behavior
|
GO:0048512 |
13 |
0.039
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.038
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.038
|
Mouse |
|
|
intrahepatic bile duct development
|
GO:0035622 |
2 |
0.038
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.038
|
|
|
|
embryonic hemopoiesis
|
GO:0035162 |
23 |
0.038
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.038
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.037
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.037
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.037
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.037
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.037
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.037
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.037
|
|
|
|
chromatin assembly
|
GO:0031497 |
13 |
0.037
|
|
|
|
face morphogenesis
|
GO:0060325 |
29 |
0.037
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.036
|
|
|
|
negative regulation of cell growth involved in cardiac muscle cell development
|
GO:0061052 |
2 |
0.036
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.036
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.036
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.036
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.036
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.036
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.036
|
|
|
|
cellular response to alcohol
|
GO:0097306 |
23 |
0.036
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.035
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.035
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.035
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.035
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.035
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
26 |
0.035
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.035
|
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.035
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.035
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.035
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.035
|
|
|
|
sister chromatid cohesion
|
GO:0007062 |
12 |
0.034
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
16 |
0.034
|
|
|
|
dendritic cell proliferation
|
GO:0044565 |
2 |
0.034
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.034
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.034
|
|
|
|
positive regulation of mitotic sister chromatid separation
|
GO:1901970 |
2 |
0.034
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.034
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.034
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.034
|
|
|
|
t helper cell differentiation
|
GO:0042093 |
28 |
0.034
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.033
|
|
|
|
neuronal stem cell maintenance
|
GO:0097150 |
17 |
0.033
|
|
|
|
regulation of cell cycle g2 m phase transition
|
GO:1902749 |
10 |
0.033
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.033
|
|
|
|
cytoplasmic mrna processing body assembly
|
GO:0033962 |
6 |
0.033
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.033
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.033
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.033
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.033
|
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.033
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.033
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
22 |
0.033
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.032
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.032
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.032
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.032
|
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.032
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.032
|
|
|
|
regulation of posttranscriptional gene silencing
|
GO:0060147 |
5 |
0.032
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.032
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.031
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.031
|
Worm |
|
|
cellular response to nitric oxide
|
GO:0071732 |
4 |
0.031
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
10 |
0.031
|
|
|
|
regulation of antibacterial peptide production
|
GO:0002786 |
1 |
0.031
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.031
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.031
|
|
|
|
cytoplasmic pattern recognition receptor signaling pathway in response to virus
|
GO:0039528 |
4 |
0.030
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.030
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.030
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.030
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.030
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.030
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.030
|
|
|
|
trachea development
|
GO:0060438 |
18 |
0.030
|
|
|
|
response to uv
|
GO:0009411 |
44 |
0.030
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.030
|
|
|
|
gastrulation with mouth forming second
|
GO:0001702 |
29 |
0.030
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.030
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.029
|
|
|
|
embryonic digestive tract development
|
GO:0048566 |
27 |
0.029
|
|
|
|
negative regulation of mammary gland epithelial cell proliferation
|
GO:0033600 |
3 |
0.029
|
|
|
|
positive regulation of antimicrobial humoral response
|
GO:0002760 |
2 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.029
|
|
|
|
collecting duct development
|
GO:0072044 |
11 |
0.029
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.029
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.029
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.029
|
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.029
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.029
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.029
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.029
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.029
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.028
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.028
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.028
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.028
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.028
|
|
